Nexalin Technology (NXL) Cash & Current Investments (2021 - 2026)
Nexalin Technology (NXL) posted Cash & Current Investments of $1.0 million for Q2 2026, down 66.51% on a QoQ basis from $3.0 million in Q1 2026, and down 90.63% year-over-year from $10.7 million in Q2 2025.
Analysis
Nexalin Technology (NXL) Cash & Current Investments (2021 - 2026) Analysis & Trends
Nexalin Technology has reported Cash & Current Investments for 6 years, with the latest figure at $1.0 million in Q2 2026.
- On a quarterly basis, Cash & Current Investments fell 90.63% year-over-year to $1.0 million in Q2 2026; TTM through Jun 2026 was $1.0 million, a 90.63% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, up 5.61% from the prior year.
- Cash & Current Investments was $1.0 million for Q2 2026 at Nexalin Technology, down from $3.0 million in the prior quarter.
- The five-year high for Cash & Current Investments was $13.7 million in Q4 2022, with the low at $848796.0 in Q2 2024.
- Average Cash & Current Investments over 5 years is $6.4 million, with a median of $6.6 million recorded in 2023.
- The sharpest annual moves came in 2022 and 2026: Cash & Current Investments soared 1964.5% in 2022, then slumped 90.63% in 2026.
- Over 5 years, Cash & Current Investments stood at $13.7 million in 2022, then slumped by 65.33% to $4.7 million in 2023, then gained by 22.69% to $5.8 million in 2024, then grew by 5.61% to $6.1 million in 2025, then tumbled by 83.62% to $1.0 million in 2026.
- The last three Cash & Current Investments figures came in at $1.0 million (Q2 2026), $3.0 million (Q1 2026), and $6.1 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.84 Bn | 174.23 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Intuitive Surgical | 128.02 Bn | 122.81 Bn | 1.96 Bn | 5.22 Bn |
| 3 | Medtronic | 117.28 Bn | 108.46 Bn | 6.34 Bn | 8.82 Bn |
| 4 | Stryker | 103.92 Bn | 100.44 Bn | 4.50 Bn | 3.48 Bn |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | 539.00 Mn |
| 6 | Edwards Lifesciences | 49.96 Bn | 45.70 Bn | 1.35 Bn | 4.25 Bn |
| 7 | Alcon | 32.86 Bn | 31.40 Bn | 1.68 Bn | 1.46 Bn |
| 8 | Dexcom | 32.25 Bn | 30.30 Bn | 830.00 Mn | 1.95 Bn |
| 9 | Steris | 20.74 Bn | 20.26 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Nexalin Technology | 3.42 Mn | 2.41 Mn | 8,897.00 | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 3.00 Mn |
| Dec 31, 2025 | 6.14 Mn |
| Sep 30, 2025 | 7.53 Mn |
| Jun 30, 2025 | 10.72 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Dec 31, 2024 | 5.81 Mn |
| Sep 30, 2024 | 9.02 Mn |
| Jun 30, 2024 | 848,796.00 |
| Mar 31, 2024 | 3.20 Mn |
| Dec 31, 2023 | 4.74 Mn |
| Sep 30, 2023 | 7.15 Mn |
| Jun 30, 2023 | 8.93 Mn |
| Mar 31, 2023 | 10.60 Mn |
| Dec 31, 2022 | 13.66 Mn |
| Sep 30, 2022 | 7.86 Mn |
| Dec 31, 2021 | 661,778.00 |